Differentiating a New Lung Cancer TX in an Evolving and Crowded Space
How can I use research to differentiate a new cancer treatment?
Situation
A pharmaceutical company sought to increase the competitiveness of their new lung cancer molecule at launch.
Solution
The client wanted to gain a deep and nuanced understanding of pain points and unmet needs for HCPs in the treatment and management of lung cancer in order to develop a customer solution to differentiate their therapy and get ahead of potential barriers to adoption.
Impact
Equipped with a nuanced understanding of the HCP experience as well as an appreciation of the true pain points across AE management and clinical decision making, the client team was able to prioritize proposed solutions for further development.
"I can see us coming back to this research throughout the year as we build out the tool. I already have slides picked out to share with project sponsors."
Predictive Analytics for Journey-Based Insights & Targeting
Unified Commercial Taxonomy for Enabling Journey-Based Analytics
Digital HCP Content Platform Orchestration
